Teachers Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$2.35M Sell
200,353
-94,410
-32% -$1.17M ﹤0.01% 1888
2018
Q4
$3.94M Hold
294,763
0.01% 1450
2018
Q3
$4.13M Buy
294,763
+3,917
+1% +$54.7K 0.01% 1560
2018
Q2
$4.57M Sell
290,846
-41,104
-12% -$715K 0.01% 1471
2018
Q1
$5.46M Sell
331,950
-620,635
-65% -$11.5M 0.01% 1296
2017
Q4
$17.2M Buy
952,585
+81,697
+9% +$1.48M 0.02% 805
2017
Q3
$16.8M Buy
870,888
+53,643
+7% +$800K 0.02% 769
2017
Q2
$9.64M Buy
817,245
+621,219
+317% +$6.75M 0.01% 1016
2017
Q1
$2.15M Buy
196,026
+11,566
+6% +$102K ﹤0.01% 1741
2016
Q4
$1.34M Buy
184,460
+57,985
+46% +$454K ﹤0.01% 2016
2016
Q3
$822K Buy
126,475
+8,340
+7% +$48.5K ﹤0.01% 2201
2016
Q2
$645K Buy
118,135
+28,112
+31% +$146K ﹤0.01% 2279
2016
Q1
$421K Hold
90,023
﹤0.01% 2434
2015
Q4
$448K Hold
90,023
﹤0.01% 2469
2015
Q3
$338K Hold
90,023
﹤0.01% 2617
2015
Q2
$541K Buy
90,023
+14,089
+19% +$86.4K ﹤0.01% 2486
2015
Q1
$425K Hold
75,934
﹤0.01% 2529
2014
Q4
$228K Hold
75,934
﹤0.01% 2850
2014
Q3
$204K Hold
75,934
﹤0.01% 2874
2014
Q2
$213K Sell
75,934
-21,474
-22% -$63.4K ﹤0.01% 2910
2014
Q1
$425K Buy
97,408
+37,410
+62% +$131K ﹤0.01% 2488
2013
Q4
$193K Hold
59,998
﹤0.01% 2874
2013
Q3
$95K Sell
59,998
-446
-0.7% -$786 ﹤0.01% 3006
2013
Q2
$105K Buy
+60,444
New +$109K ﹤0.01% 2985

Other funds holding CORT

Teachers Advisors's CORT Position: Q1 2019 in Review

Teachers Advisors reduced its Corcept Therapeutics (CORT) stake by 32% in Q1 2019, selling an estimated $1.17M and leaving 200,353 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

Teachers Advisors first reported a position in CORT in Q2 2013 and has held it in 24 quarters since. The position peaked at $17.2M in Q4 2017. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.

  • Teachers Advisors held 200,353 shares of Corcept Therapeutics worth $2.35M as of Q1 2019.
  • Teachers Advisors sold 94,410 Corcept Therapeutics shares in Q1 2019, an estimated $1.17M.
  • Corcept Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1888 holding.
  • Teachers Advisors first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Corcept Therapeutics position peaked at $17.2M in Q4 2017.
  • 208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.